Copy reference, caption or embed code

Figure 3 - Cytopathic effects of activated parasporal inclusion proteins produced from Iraqi isolates of Bacillus thuringiensis

Figure 3: Normal human lymphocyte and CLL cancerous cell treated with activated parasporal protein produced by isolates of B. thuringiesis. A-Normal human lymphocytes treated for 12 hours with activated parasporal protein of BtA1 and BtA5. B-Normal human lymphocytes treated for one hours either activated parasporal protein of BtA2, 3, 4 or 6. C-CLL cancerous cells treated for 12 hours with either activated parasporal protein of BtA1 or BtA5. D-Cell lyses and ruptured of CLL cancerous cells treated for 12 hours with activated parasporal protein of BtA2, 3, 4 and 6.
Normal human lymphocyte and CLL cancerous cell treated with activated parasporal protein produced by isolates of B. thuringiesis. A-Normal human lymphocytes treated for 12 hours with activated parasporal protein of BtA1 and BtA5. B-Normal human lymphocytes treated for one hours either activated parasporal protein of BtA2, 3, 4 or 6. C-CLL cancerous cells treated for 12 hours with either activated parasporal protein of BtA1 or BtA5. D-Cell lyses and ruptured of CLL cancerous cells treated for 12 hours with activated parasporal protein of BtA2, 3, 4 and 6.
Go to figure page
Reference
Caption
Embed code